Inventor · disambiguated record
Kevin Yang
Also filed as: YANG KEVIN · YANG KEVIN C · YANG KEVIN CHAO
34 granted patents·9 pending applications·773 citations·filing 2001–2025
98Inventor score
Top patents by PatentIndex Score
43 records- 0198US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 0298US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0397US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 0497US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0597US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0697US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0797US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0896US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 0996US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 1096US6645990B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2002·Granted Nov 11, 2003·172 cites·18 claims
- 1195US11053226B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Jul 6, 2021·25 cites·48 claims
- 1295US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 1395US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 1495US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1595US7196104B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2003·Granted Mar 27, 2007·120 cites·13 claims
- 1695US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 1793US9066954B2Fused heterocyclic derivatives and methods of useAMGEN INC·Filed 2013·Granted Jun 30, 2015·22 cites·9 claims
- 1892US8524900B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Granted Sep 3, 2013·23 cites·8 claims
- 1992US7928140B2Benzothiazole PI3 kinase modulators for cancer treatmentAMGEN INC·Filed 2008·Granted Apr 19, 2011·32 cites·17 claims
- 2089US8088794B2Substituted amide derivatives and methods of useKIM TAE-SEONG·Filed 2010·Granted Jan 3, 2012·14 cites·14 claims
- 2185US2025362134A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 2284US7307088B2Substituted anthranilic amide derivatives and methods of useAMGEN INC·Filed 2003·Granted Dec 11, 2007·24 cites·18 claims
- 2383US8685983B2Method of treating cancer with substituted amide derivativesKIM TAE-SEONG·Filed 2011·Granted Apr 1, 2014·7 cites·5 claims
- 2482US2025057817A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 2580US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 2680US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 2780US7320992B2Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of useAMGEN INC·Filed 2004·Granted Jan 22, 2008·15 cites·38 claims
- 2877US8729074B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2010·Granted May 20, 2014·5 cites·2 claims
- 2975US7414134B2B1 bradykinin receptor antagonistsAMGEN INC·Filed 2005·Granted Aug 19, 2008·2 cites·31 claims
- 3074US2022168280A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2022·Application pending·0 cites
- 3170US8415376B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2009·Granted Apr 9, 2013·1 cites·9 claims
- 3270US7662811B21,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of useAMGEN INC·Filed 2005·Granted Feb 16, 2010·1 cites·13 claims
- 3367US7393852B2Piperazine derivatives and methods of useAMGEN INC·Filed 2004·Granted Jul 1, 2008·3 cites·42 claims
- 3465US7425631B2Compounds and methods of useAMGEN INC·Filed 2004·Granted Sep 16, 2008·2 cites·6 claims
- 3564US7199244B2Cyclic amine derivatives and methods of useARRAY BIOPHARMA INC·Filed 2004·Granted Apr 3, 2007·2 cites·48 claims
- 3657US2009048224A1Compounds and methods of useAMGEN INC·Filed 2008·Application pending·0 cites
- 3756US2008249106A1Novel B1 bradykinin receptor antagonistsAMGEN INC·Filed 2008·Application pending·0 cites
- 3854US2009054460A1Piperazine derivatives and methods of useCHEN JIAN J·Filed 2008·Application pending·0 cites
- 3949US8314087B2Nitrogen-containing heterocyclyl ketones and methods of useALBRECHT BRIAN K·Filed 2008·Granted Nov 20, 2012·0 cites·6 claims
- 4047US2012107275A1Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Application pending·0 cites
- 4146US2023116602A1Mcl1 inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2020·Application pending·0 cites
- 4238US2002173507A1Urea compounds and methods of usesFiled 2001·Application pending·0 cites
- 4330US8431563B2Compounds that interact with glucokinase regulatory protein for the treatment of diabetesASHTON KATE·Filed 2011·Granted Apr 30, 2013·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →